| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RWDD2B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | GAGE12G | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | TMEM106B | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | ARMC5 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | NKX1-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | FOXJ2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRIX1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | INPPL1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PRRC1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | IGFBP3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
